What are the side effects of lemborexant?

As a new dual orexin receptor antagonist, lemborexant has attracted widespread attention in the field of insomnia treatment. It helps patients fall asleep more easily and stay asleep throughout the night by inhibiting the orexin neuropeptide system in the brain that maintains wakefulness. Compared with traditional benzodiazepine sleeping pills, leborexan is considered to have better safety and side effect control due to its unique mechanism of action. However, despite being generally well tolerated, use of this drug may cause a range of adverse effects, particularly in the central nervous system.

In clinical studies, the most common side effects include drowsiness, fatigue, slowed movements, headaches, and nightmares or unusual dreams. Most of these symptoms are mild to moderate and usually resolve as the body adapts. However, for some people, Lebrasin may cause more complex sleep-related behavioral problems, such as sleepwalking, driving, eating, or talking on the phone while not fully awake. Such behavior carries risks, which may be exacerbated when combined with alcohol or other central nervous system depressants.

Additionally, some patients report sleep paralysis, a brief inability to move or speak when falling asleep or waking up, usually lasting a few seconds to minutes, along with hypnotic hallucinations such as vivid or even disturbing dreams. There are also rare cases of symptoms similar to cataplexy, such as temporary lower limb weakness without obvious triggers.

It is worth noting that leborexan may also affect mood, especially in patients with a history of depression. Some people may experience worsening of depression or rare suicidal ideation. Therefore, during the period of using this drug, doctors need to pay close attention to the patient's psychological and behavioral changes, and adjust the medication or take further intervention if necessary. Overall, while lemborexant can effectively improve sleep, it is also necessary to be alert to possible neuropsychiatric-related adverse reactions, especially among high-risk groups, which require careful evaluation and individualized management.

Reference materials:https://en.wikipedia.org/wiki/Lemborexant